Title CD8+ cell density gradient across the tumor epithelium-stromal interface of non-muscle invasive papillary urothelial carcinoma predicts recurrence-free survival after BCG immunotherapy /
Authors Drachneris, Julius ; Rasmusson, Allan ; Morkūnas, Mindaugas ; Fabijonavičius, Mantas ; Čekauskas, Albertas ; Jankevičius, Feliksas ; Laurinavičius, Arvydas
DOI 10.3390/cancers15041205
Full Text Download
Is Part of Cancers.. Basel : MDPI. 2023, vol. 15, iss. 4, art. no. 1205, p. [1-12].. eISSN 2072-6694
Keywords [eng] anti-tumor immune response ; artificial intelligence ; computational pathology ; digital pathology ; immunotherapy ; predictive model ; tumor microenvironment ; tumor-infiltrating lymphocytes
Abstract [eng] BACKGROUND: Bacille Calmette-Guerin (BCG) immunotherapy is the first-line treatment in patients with high-risk non-muscle invasive papillary urothelial carcinoma (NMIPUC), the most common type of bladder cancer. The therapy outcomes are variable and may depend on the immune response within the tumor microenvironment. In our study, we explored the prognostic value of CD8+ cell density gradient indicators across the tumor epithelium-stroma interface of NMIPUC. METHODS: Clinical and pathologic data were retrospectively collected from 157 NMIPUC patients treated with BCG immunotherapy after transurethral resection. Whole-slide digital image analysis of CD8 immunohistochemistry slides was used for tissue segmentation, CD8+ cell quantification, and the assessment of CD8+ cell densities within the epithelium-stroma interface. Subsequently, the gradient indicators (center of mass and immunodrop) were computed to represent the density gradient across the interface. RESULTS: By univariable analysis of the clinicopathologic factors, including the history of previous NMIPUC, poor tumor differentiation, and pT1 stage, were associated with shorter RFS (p < 0.05). In CD8+ analyses, only the gradient indicators but not the absolute CD8+ densities were predictive for RFS (p < 0.05). The best-performing cross-validated model included previous episodes of NMIPUC (HR = 4.4492, p = 0.0063), poor differentiation (HR = 2.3672, p = 0.0457), and immunodrop (HR = 5.5072, p = 0.0455). CONCLUSIONS: We found that gradient indicators of CD8+ cell densities across the tumor epithelium-stroma interface, along with routine clinical and pathology data, improve the prediction of RFS in NMIPUC.
Published Basel : MDPI
Type Journal article
Language English
Publication date 2023
CC license CC license description